A dual signal amplification method for miR-204 assay by combining chimeric molecular beacon with double-stranded nuclease

2018 ◽  
Vol 10 (48) ◽  
pp. 5834-5841 ◽  
Author(s):  
Hao Liu ◽  
Jialong Fan ◽  
Weiping Liu ◽  
Chunyi Tong ◽  
Zhenhua Xie ◽  
...  

Due to the miRNA's key roles in early disease diagnosis, an assay based on chimeric molecular beacon was constructed for miR204 detection with LOD lower to 50 pM.

The Analyst ◽  
2019 ◽  
Vol 144 (6) ◽  
pp. 1995-2002 ◽  
Author(s):  
Mei-Ling Gao ◽  
Fang He ◽  
Bin-Cheng Yin ◽  
Bang-Ce Ye

An increasing number of studies have found that circulating exosomes play a vital role in the occurrence and metastasis of cancer.


2014 ◽  
Vol 61 ◽  
pp. 370-373 ◽  
Author(s):  
Zhimin Cai ◽  
Yiying Chen ◽  
Chunshui Lin ◽  
Yanfang Wu ◽  
Chaoyong James Yang ◽  
...  

The Analyst ◽  
2012 ◽  
Vol 137 (16) ◽  
pp. 3620 ◽  
Author(s):  
Hongjun Lin ◽  
Jingrui Huo ◽  
Aihong Zhang ◽  
Yingfu Liu ◽  
Qingming Wang ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 319
Author(s):  
Hee Cheol Yang ◽  
Won Jong Rhee

Because cancers are heterogeneous, it is evident that multiplexed detection is required to achieve disease diagnosis with high accuracy and specificity. Extracellular vesicles (EVs) have been a subject of great interest as sources of novel biomarkers for cancer liquid biopsy. However, EVs are nano-sized particles that are difficult to handle; thus, it is necessary to develop a method that enables efficient and straightforward EV biomarker detection. In the present study, we developed a method for single step in situ detection of EV surface proteins and inner miRNAs simultaneously using a flow cytometer. CD63 antibody and molecular beacon-21 were investigated for multiplexed biomarker detection in normal and cancer EVs. A phospholipid-polymer-phospholipid conjugate was introduced to induce clustering of the EVs analyzed using nanoparticle tracking analysis, which enhanced the detection signals. As a result, the method could detect and distinguish cancer cell-derived EVs using a flow cytometer. Thus, single step in situ detection of multiple EV biomarkers using a flow cytometer can be applied as a simple, labor- and time-saving, non-invasive liquid biopsy for the diagnosis of various diseases, including cancer.


Sign in / Sign up

Export Citation Format

Share Document